BioSpace News Archive

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Festival of Biologics

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that chairman and CEO Dr. Hans S. Keirstead will deliver an opening keynote at the World Immunotherapy Congress, a submeeting of the Festival of Biologics taking place March 9-11 in San Diego.

March 9, 2022
·
2 min read
Business

Lipocine Announces Financial Results for the Year Ended December 31, 2021

Lipocine Inc. today announced financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.

March 9, 2022
·
9 min read
Mikra Cellular Sciences Receives $8.5 Million in Funding to Launch Novel Therapeutic Product

Mikra Cellular Sciences Inc. (“Mikra”), a biosciences company driving breakthrough applications of bioactive compounds to positively impact human health and intervene before pharmaceuticals are necessary, today announced $8.5 million in funding from its parent company, Lifeist Wellness Inc.

March 9, 2022
·
3 min read
Policy

Leidos awarded NIAID contract to support biomedical research

Leidos, a FORTUNE® 500 science and technology leader, was recently awarded a new prime contract to provide biomedical preclinical and development capabilities to support the National Institute of Allergy and Infectious Diseases.

March 9, 2022
·
3 min read
BioMidwest

ENDRA Life Sciences to Participate in Two March 2022 Investor Conferences

ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announces that management will participate in two investor conferences during March.

March 9, 2022
·
1 min read
Biotech Bay

ReCode Therapeutics to Present at Oppenheimer 32nd Annual Healthcare Conference

ReCode Therapeutics announced that Shehnaaz Suliman, M.D., MBA, M.Phil, chief executive officer of ReCode Therapeutics will present a corporate overview at the upcoming Oppenheimer 32nd Annual Healthcare Conference being held virtually from March 15-16, 2022.

March 9, 2022
·
1 min read
Business

Third Harmonic Bio Appoints Robert Ho as Chief Financial Officer

Third Harmonic Bio, a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for the treatment of severe allergy and inflammation, announced the appointment of Robert Ho as Chief Financial Officer.

March 9, 2022
·
3 min read
Lone Star Bio

Savara to Present at Oppenheimer’s 32nd Annual Healthcare Conference

Savara to Present at Oppenheimer’s 32nd Annual Healthcare Conference.

March 9, 2022
·
1 min read
Business

Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene Therapy

Twist Bioscience Corporation and Kriya Therapeutics, Inc. today announced an antibody discovery agreement for antibodies delivered using adeno-associated viral (AAV) gene therapy in therapeutic oncology applications.

March 9, 2022
·
5 min read
Genetown

Palleon Pharmaceuticals to Present Preclinical Data on Lead Program E-602 and Novel Bifunctional PD-L1-Targeted Sialidase at AACR Annual Meeting

Palleon Pharmaceuticals today announced two poster presentations at the American Association for Cancer Research Annual Meeting in New Orleans, La., from April 8-13, 2022.

March 9, 2022
·
2 min read